About: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
value	Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
subject	Therapy Immunostimulants Pyrimidones World Health Organization essential medicines
part of	Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
is hasSource of	covid:ann/target/ea314296c0a4eb1d70a80380865500e8865adcab covid:ann/target/65febc9d4d5232da4de15509bdc56074ec4ca8eb covid:ann/target/29e3578ca7476155972d7b0e0acea693da8d85cd covid:ann/target/b8996807592a87b55bfd574c426fdce7f7a90e14 covid:ann/target/30d44c6ea8c7aa0f7fb27339e0357d0d30582971 covid:ann/target/bddfb348713c9c934e95ca0142f64b97b0c8b737 covid:ann/target/4c726826acca33159da18c9f9450a98d983395d5 covid:ann/target/51b9886203ff417391de0adeab033fc5ef1415ea covid:ann/target/dfd7fedff5b6746bce113005f409b21e6307606f covid:ann/target/e1f0a7b4cdf2d04a91751882c670567deefcba7a covid:ann/target/1059465a3c85653219bc6c55669d630398835be5 covid:ann/target/6bc65c03e67475988e41ec0a43fc64a3a71b1877 covid:ann/target/b6ca15bf438f0cd8a597cc8ae0d379ae8a39e0c2 covid:ann/target/bec4c0db4e0da77d480ead67e9944028cb6a9815 covid:ann/target/0e64ba2c14a9409794426663d0ae56b0da8f8bbd covid:ann/target/2d60303000ff34dd16fb49cbe6d9631662e76450 covid:ann/target/119745f302e394ebe9c4ab2b6c2b70e708d87592 covid:ann/target/86c282c2c10b67394f1d3fa8e71a9b0f39f3bbbc covid:ann/target/e9722065debad6c305e045655859f8e5fe71e591 covid:ann/target/5a56998a31fe6a36d3eacffe3e39a08e5b4fa3c4 covid:ann/target/07189a61231264b24b5d4fd82ab5b58511db2c49 covid:ann/target/252ff70fde2bb2f63553ee11125b265e1cdb5391 covid:ann/target/959fc035d45db19c029e20c2adb4f71706197aeb covid:ann/target/78f74fc63c45e44255f2dfe0d8ef8277b4efaffa covid:ann/target/6b73e19ec4bac4c69641318d8d84efa85535ec34 covid:ann/target/a0bd7b85d9e7566be29336b5139c6cad521f4fd7 covid:ann/target/41c61c3b6531e31caf81db3070a7c9190a06a394 covid:ann/target/9ffda8810832f216de2394b067a49ee19a23fa1d covid:ann/target/16889ff22e7de0485debd88c501d0c7b89b321fd covid:ann/target/faa0ca717bbb10c1ff3dea298d7fb87a14dfd677 covid:ann/target/05863c28a53f5e6613b1c49efe8f4ffc971b2f4f covid:ann/target/d31a98aad679f453bd106876a01083178a38928a
is resource representing a document's title of	Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software